<DOC>
	<DOCNO>NCT00154843</DOCNO>
	<brief_summary>Primary : To determine factor affect absorption serum level lycopene supplementation . Secondary : 1 . To evaluate general safety tolerability oral lycopene 15 30 mg per day 12 week . 2 . To determine lycopene effect reduce serum level prostate specific antigen ( PSA ) relieve low urinary tract symptom ( LUTS ) relation prostate hypertrophy evaluate International Prostate Symptom Score ( I-PSS ) .</brief_summary>
	<brief_title>A Clinical Study Determine Factors Affecting Absorption Serum Levels Lycopene After Supplementation</brief_title>
	<detailed_description>This uncontrolled intervention study eligible male subject ( N=60 ) , two-week washout , randomize receive lycopene either 15 30 mg per day 12 week . About equal number subject randomize either 15 30 mg lycopene ( 30 subject arm ) . The study expect finish 2 year . The study expect finish 2 year . Concerning expect dropout rate 10 % , 66 subject recruit study .</detailed_description>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>Male subject age 40 old pathologicallyproven prostate cancer cancer . Patients negative prostate biopsy still acceptable . Subjects PSA 2.5 20.0 ng/ml . Subjects understand study procedure agree participate study provide write informed consent schedule blood urine sample . Subjects whose liver function renal function test within normal range . Subjects may fluctuate serum PSAs , urinary tract infection , prostatitis , acute urinary retention , receive radiotherapy pelvis , etc . Subjects receive prostate surgery biopsy within 6 week initiation lycopene supplementation . Subjects may receive prostate surgery biopsy within 12 week initiation lycopene supplementation . Subjects know allergic reaction carotenoid include lycopene . Subjects participate participate clinical trial . Subjects take medication may alter serum PSA level , 5alpha reductase inhibitor ( eg . finasteride ) , sex steroid hormonal agent ( eg . luteinizing hormone release hormone agonist , cyproterone acetate , flutamide , bicalutamide , megesterol acetate , etc. ) . Subjects may require increased dosage medication low urinary tract symptom ( LUTS ) 12 week protocol treatment . Subjects put medication LUTS entry stabilize disease still acceptable . These medication include , note limit , selective nonselective alphablockers anticholinergic . Subjects clinical gastrointestinal malabsorption regardless etiology .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Lycopene</keyword>
	<keyword>BPH</keyword>
	<keyword>PSA</keyword>
	<keyword>IPSS</keyword>
</DOC>